1. Home
  2. LPSN vs TELA Comparison

LPSN vs TELA Comparison

Compare LPSN & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LivePerson Inc.

LPSN

LivePerson Inc.

N/A

Current Price

$3.00

Market Cap

37.5M

Sector

Technology

ML Signal

N/A

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

N/A

Current Price

$0.91

Market Cap

36.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LPSN
TELA
Founded
1995
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.5M
36.7M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
LPSN
TELA
Price
$3.00
$0.91
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
N/A
$3.31
AVG Volume (30 Days)
92.8K
63.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.80
EPS
N/A
N/A
Revenue
$249,838,000.00
$69,300,000.00
Revenue This Year
N/A
$18.41
Revenue Next Year
N/A
$15.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.56
52 Week Low
$0.39
$0.67
52 Week High
$7.54
$2.48

Technical Indicators

Market Signals
Indicator
LPSN
TELA
Relative Strength Index (RSI) 47.50 52.61
Support Level $2.94 $0.67
Resistance Level $4.23 $0.93
Average True Range (ATR) 0.19 0.09
MACD 0.07 0.02
Stochastic Oscillator 46.32 81.18

Price Performance

Historical Comparison
LPSN
TELA

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: